EUVIMEDEUVIMED entdecken
Crossref

FZHWT alleviates chronic atrophic gastritis by inhibiting inflammatory pathways and promoting mucosal repair

Xuehui Ma, Yongli Wang, Lingjing Kong, Wen Zhu, Xin Zhou, Jian Li, Wei Zhao, Xiaoyun Mao, Guangxing Tan

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xuehui Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preclinical, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi 214200, China. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Drugs, Chinese Herbal, Gastric Mucosa, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic atrophic gastritis (CAG) is a prevalent chronic digestive disorder that, through sustained inflammation, can lead to severe mucosal damage and even gastric cancer. Current treatments offer limited efficacy, whereas Fu-Zheng-Huo-Wei Decoction (FZHWT), a traditional Chinese medicine (TCM) formulation, shows promising potential in treating CAG. PURPOSE: This study aims to identify the key active components of FZHWT and evaluate its therapeutic effects on CAG. METHODS: UPLC-MS/MS was used to identify the bioactive compounds in FZHWT. A CAG rat model was established to assess its therapeutic effects, and transcriptome sequencing was conducted to identify key targets and mechanisms. A CAG cell model was used for validation of the transcriptomic findings, and histological techniques and molecular biology methods were employed for further validation. RESULTS: A total of 1362 chemical components were identified in FZHWT, of which 25 are bioavailable compounds. Differential metabolite analysis revealed four key active ingredients: Nicotiflorin, Stachydrine, 5-O-p-Coumaroylquinic acid, and N-(4-oxopentyl)-acetamide. In the CAG rat model, FZHWT significantly reduced inflammation and gastric mucosal damage. Transcriptome sequencing highlighted Sema5a as a key target and revealed the involvement of several inflammatory signaling pathways. In the CAG cell model, FZHWT alleviated CAG by inhibiting inflammation and promoting gastric mucosal repair. CONCLUSIONS: FZHWT demonstrates significant therapeutic potential in treating CAG by modulating inflammatory pathways and promoting mucosal repair. This study provides new insights into the treatment of CAG and supports the modernization of multi-component TCM formulas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastritis, AtrophicDrugs, Chinese HerbalGastric MucosaAnti-Inflammatory AgentsAnimalsRatsRats, Sprague-DawleyMaleHumansDisease Models, AnimalSignal TransductionChronic Disease

Stichwörter der Autor:innen

Chronic atrophic gastritisFu-Zheng-Huo-Wei decoctionInflammatoryMucosal repair

Substanzen

Drugs, Chinese HerbalAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Preclinical, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi 214200, China.
  • Department of Preclinical, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi 214200, China. Electronic address: wxzy077@njucm.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ma, X., Wang, Y., Kong, L., Zhu, W., Zhou, X., Li, J., Zhao, W., Mao, X., & Tan, G. (2025). FZHWT alleviates chronic atrophic gastritis by inhibiting inflammatory pathways and promoting mucosal repair. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114473

Vancouver

Ma X, Wang Y, Kong L, Zhu W, Zhou X, Li J, et al. FZHWT alleviates chronic atrophic gastritis by inhibiting inflammatory pathways and promoting mucosal repair. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114473

BibTeX
@article{Ma2025,
  author = {Ma, Xuehui and Wang, Yongli and Kong, Lingjing and Zhu, Wen and Zhou, Xin and Li, Jian and Zhao, Wei and Mao, Xiaoyun and Tan, Guangxing},
  title = {FZHWT alleviates chronic atrophic gastritis by inhibiting inflammatory pathways and promoting mucosal repair},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114473}
}
Kostenlos starten →